Share on

Middle East and Africa Vascular Graft Market Research Report – Segmented By Raw Material, Product, End-User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 7428
Pages: 145
Formats: report pdf report excel report power bi report ppt

MEA Vascular Graft Market Size (2023 to 2028)

The Middle East and Africa Vascular Graft Market size are expected to grow at a sluggish rate between 2023 and 2028.

The MEA vascular graft market is projected to be fuelled by the proliferation of chronic diseases such as diabetes, cardiovascular diseases, renal disease with the rise in the elderly population. On the other hand, the prevalence of kidney disease in the UAE has increased by more than 7.4 percent. In Saudi Arabia, nearly more than 16,000 people are suffering from renal failure. A vascular graft is a surgical operation that reconnects the blood arteries to shift blood flow from one part to another.

The other factors, such as the constant change in lifestyles, physical inactivity, eating, smoking, and alcoholism, increase the risk of aneurysms, increasing the demand and need for a vascular graft. In addition, according to the national survey, more than 20 percent of people in South Africa smoke cigarettes, further increase the growth of the vascular graft market.

Survival rates by using a vascular prosthesis are more than 95 percent in most of the centers. Also, with the increase in the new developments and advancements in technology with various improvements in the materials and technologies such as advancements in the scaffold materials vascular materials, the market is expected to expand significantly during the forecast period. Furthermore, the improvements in tissue engineering making compatible grafts with suitable diameters are driving the demand for growth in the MEA vascular graft market. In addition, an increase in the changing preferences of minimally invasive surgical procedures over open surgeries is driving the market growth of vascular graft.

The increase in the high costs of the treatments and the presence of low reimbursement policies and expenditures are limiting the market growth of the vascular graft. Also, the risk associated with the product failure, which leads to recalling the faulty products, affects the market growth in the MEA region.

This research report on the Middle East and Africa vascular graft market has been segmented and sub-segmented into the following categories:

By Product: 

  • Peripheral Vascular Graft
  • Endovascular Aneurysm Repair Stent Grafts
  • Hemodialysis Access Graft

By Raw Material: 

  • Biosynthetic
  • Polyester
  • Polyurethane (PU)
  • Polytetrafluoroethylene (PTFE)

By End-User: 

  • Ambulatory Surgical Centers
  • Hospitals

By Application: 

  • Coronary Artery Disease
  • Aneurysm
  • Vascular Occlusion
  • Renal Failure
  • Others

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East and Africa have an untapped market, and key players are slowly expanding to this region, which is crucial for the market's growth in this region.

The UAE vascular graft market is estimated to witness a significant share in the MEA vascular graft market during the forecast period. The market growth is attributed to the increase in the prevalence of the chronic disease. Therefore, the prevalence of such chronic diseases is estimated to raise the demand for vascular grafts in the coming years. Also, there has been an increase in cardiovascular diseases and chronic kidney diseases, which would drive the market growth.

The South African vascular graft market is estimated to be growing at a promising CAGR during the forecast period as the healthcare industry in the country focuses majorly on patient care. In addition, the increase in the new developments and advancements in the technology for developing innovative and more convenient products further contributing to market growth.

The Saudi Arabia vascular graft market is also expected to considerably growth due to the initiatives and funding from government and non-government firms in the research process and the presence of market players.

KEY MARKET PLAYERS:

Endologix Inc., LeMaitre Vascular, Inc., MAQUET Holding B.V.B. Braun Melsungen AG, & Co. KG, Medtronic plc, C. R. Bard, Inc., Cardinal Health Inc., Cook Medical Inc., Terumo Corporation, and W. L. Gore & Associates, Inc. are the key players in the Middle East and Africa Vascular Graft Market.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample